Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01074151 · ClinicalTrials.gov registry record
The Cymbalta Pregnancy Registry
A clinical trial of Pregnancy, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- 144
- Enrollment target
- 1
- Study location
NCT01074151 is a study of Pregnancy that has completed, run by Eli Lilly and Company. The registered enrollment target is 144 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01074151, a study of Pregnancy, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
The Cymbalta Pregnancy Registry is a U.S. based Registry designed to monitor women who are exposed to Cymbalta (duloxetine) during pregnancy. This is an observational, exposure-registration and follow-up registry.
Conditions Studied
Interventions
- DRUG duloxetine
Study Locations (1)
North Carolina
- The Cymbalta Pregnancy Registry Call Center - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2009-07 |
| Est. Completion | 2021-07-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01074151
The ClinicalTrials.gov registry entry for NCT01074151 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (83% lower). The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which duloxetine is the first listed.
NCT01074151 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01074151 about?
NCT01074151 is a clinical study titled "The Cymbalta Pregnancy Registry". The Cymbalta Pregnancy Registry is a U.S. based Registry designed to monitor women who are exposed to Cymbalta (duloxetine) during pregnancy. This is an observational, exposure-registration and follow-up registry.
What is the current status of trial NCT01074151?
This trial is currently completed. The enrollment target is 144 participants. The study started on 2009-07. Estimated completion is 2021-07-26.
What conditions does trial NCT01074151 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT01074151?
The interventions under investigation include: duloxetine (DRUG).
Who is sponsoring clinical trial NCT01074151?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01074151 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.